Rye bread benefits
A recent study has been carried out to examine why postprandial insulin is lowered following the intake of rye bread compared with wheat bread.
A recent study has been carried out to examine why postprandial insulin is lowered following the intake of rye bread compared with wheat bread.1
A sourdough fermented endosperm rye bread and a standard white wheat bread were served to 16 healthy subjects, in test portion sizes of 50 g. Blood samples were taken over 4 hours to measure glucose and insulin concentrations. Gastric emptying rates were also measured. Changes in the plasma metabolome were examined by applying a comprehensive two-dimensional gas chromatography coupled to time-of-flight mass spectrometry metabolomics platform.
It was found that plasma insulin response to rye bread was lower than to wheat bread at 30, 45 and 60 min after intake, and plasma glucose response was significantly higher at 90 min after rye bread intake than wheat bread intake. The starch hydrolysis rate was higher for rye bread than wheat bread, contrary to the in vitro protein digestibility.
The study concluded that there were potential health benefits in rye bread linked to the changes in plasma amino acids and metabolites.
1. Kaija Poutanen et al., Nutrition Journal, 10, 116 (2011).
This story originally appeared in The Column. Click here to view that issue.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.
